Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent

NCT01081821 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: single dose NJ-39758979/ matching placebo
DRUG: multi-dose JNJ-39758979 /matching placebo

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.